Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Marie Y Moresco

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Current Opinion in Virology|March 24, 2012
Resisting viral infection: the gene by gene approachEva Marie Y Moresco, Bruce Beutler
Tissue Barriers|March 26, 2014
Linking membrane trafficking and intestinal homeostasisEva Marie Y Moresco, Katharina Brandl
Immunity|April 23, 2011
Special delivery: granulin brings CpG DNA to Toll-like receptor 9Eva Marie Y Moresco, Bruce Beutler
The American Journal of Pathology|April 24, 2013
Going forward with genetics: recent technological advances and forward genetics in miceEva Marie Y Moresco, Xiaohong Li, Bruce Beutler
Nature Communications|December 12, 2025
Structural insights into GM4951 as a lipid droplet GTPase regulating hepatic lipid metabolismRishi Raj, Yiao Jiang, Rahul Kumar Jha, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|October 10, 2015
Current strategies for mutation detection in phenotype-driven screens utilising next generation sequencingMichelle M Simon, Eva Marie Y Moresco, Katherine R Bull, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2023
Essential requirement for IER3IP1 in B cell developmentXue Zhong, James J Moresco, Katie Keller, et al.
Disease Models & Mechanisms|August 17, 2023
The dual lipid desaturase/hydroxylase DEGS2 controls phytoceramide levels necessary to counter intestinal inflammationRan Song, Aaron Fond, Xiaohong Li, et al.
The Journal of Experimental Medicine|April 16, 2024
Viable mutations of mouse midnolin suppress B cell malignanciesXue Zhong, Nagesh Peddada, James J Moresco, et al.
Journal of Medicinal Chemistry|June 29, 2022
Next-Generation Diprovocims with Potent Human and Murine TLR1/TLR2 Agonist Activity That Activate the Innate and Adaptive Immune ResponseMing-Hsiu Yang, Jamie L Russell, Yuto Mifune, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Current Opinion in Virology|March 24, 2012
Resisting viral infection: the gene by gene approachEva Marie Y Moresco, Bruce Beutler
Tissue Barriers|March 26, 2014
Linking membrane trafficking and intestinal homeostasisEva Marie Y Moresco, Katharina Brandl
Immunity|April 23, 2011
Special delivery: granulin brings CpG DNA to Toll-like receptor 9Eva Marie Y Moresco, Bruce Beutler
The American Journal of Pathology|April 24, 2013
Going forward with genetics: recent technological advances and forward genetics in miceEva Marie Y Moresco, Xiaohong Li, Bruce Beutler
Nature Communications|December 12, 2025
Structural insights into GM4951 as a lipid droplet GTPase regulating hepatic lipid metabolismRishi Raj, Yiao Jiang, Rahul Kumar Jha, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|October 10, 2015
Current strategies for mutation detection in phenotype-driven screens utilising next generation sequencingMichelle M Simon, Eva Marie Y Moresco, Katherine R Bull, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2023
Essential requirement for IER3IP1 in B cell developmentXue Zhong, James J Moresco, Katie Keller, et al.
Disease Models & Mechanisms|August 17, 2023
The dual lipid desaturase/hydroxylase DEGS2 controls phytoceramide levels necessary to counter intestinal inflammationRan Song, Aaron Fond, Xiaohong Li, et al.
The Journal of Experimental Medicine|April 16, 2024
Viable mutations of mouse midnolin suppress B cell malignanciesXue Zhong, Nagesh Peddada, James J Moresco, et al.
Journal of Medicinal Chemistry|June 29, 2022
Next-Generation Diprovocims with Potent Human and Murine TLR1/TLR2 Agonist Activity That Activate the Innate and Adaptive Immune ResponseMing-Hsiu Yang, Jamie L Russell, Yuto Mifune, et al.
Pageof 7